Compound information
- Natural Products
- ZC864095
- Molecular Formula
- C20H31N5O5
- Molecular Weight
- 421.232519092 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[[(2R)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C20H31N5O5/c1-13(2)11-16(25-20(29)30-12-14-7-4-3-5-8-14)17(26)24-15(18(27)28)9-6-10-23-19(21)22/h3-5,7-8,13,15-16H,6,9-12H2,1-2H3,(H,24,26)(H,25,29)(H,27,28)(H4,21,22,23)/t15-,16-/m1/s1
- InChI Key
- KFBDTHSSJMQGMW-HZPDHXFCSA-N
- SMILES
- CC(C)C[C@@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)O
- Source
- ZINC000004043726
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 166.63 Å2 | LogP | 1.038 |
LogS | -2.336 | LogD | 0.528 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.009 | Pgp substrate | 0.988 |
HIA | 0.066 | F20 % | 0.99 |
F30 % | 0.037 | Caco-2 | -6.519 |
MDCK | -5.877 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.321 | PPB | 42.182 |
VD | 0.375 | Fu | 0.571 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.531 |
CYP2A6 substrate | 0.207 | CYP2B6 substrate | 0.372 |
CYP2C19 inhibitor | 0.032 | CYP2C19 substrate | 0.369 |
CYP2C8 substrate | 0.536 | CYP2C9 inhibitor | 0.154 |
CYP2C9 substrate | 0.996 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.262 | CYP2E1 substrate | 0.294 |
CYP3A4 inhibitor | 0.039 | CYP3A4 substrate | 0.846 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.809 | CL | 4.2 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.378 | Hepatotoxicity | 0.026 |
Mutagenicity | 0.018 | Rat Oral Acute Toxicity | 0.021 |
FDAMDD | 0.072 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.067 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.773 | IGC50 | 2.079 |
LC50FM | 3.545 | LC50DM | 3.76 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.407 | NR-AR-LBD | 0.409 |
NR-AhR | 0.004 | NR-Aromatase | 0.021 |
NR-ER | 0.404 | NR-ER-LBD | 0.348 |
NR-PPAR-gamma | 0.454 | SR-ARE | 0.113 |
SR-ATAD5 | 0.291 | SR-HSE | 0.043 |
SR-MMP | 0.009 | SR-p53 | 0.041 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.